Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|May 10, 2020
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibodyYing-Jun Chang, Lan-Ping Xu, Yu Wang, et al.
Bone Marrow Transplantation|January 19, 2019
Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factorsMeng Lv, Shu-Zhen Zhai, Yu Wang, et al.
Journal of Hematology & Oncology|March 20, 2019
Early myeloid-derived suppressor cells (HLA-DR-/lowCD33+CD16-) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCTKe Wang, Meng Lv, Ying-Jun Chang, et al.
Imeta|December 31, 2025
Homoharringtonine suppresses acute myeloid leukemia progression by orchestrating EWSR1 phase separation in an m6A-YTHDF2-dependent mechanismTing-Ting Liu, Li-Ting Chen, Xu-Ying Pei, et al.
JCI Insight|January 6, 2022
Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantationXing-Xing Yu, Qian-Nan Shang, Xue-Fei Liu, et al.
Acta Pharmacologica Sinica|May 27, 2024
Human amniotic epithelial stem cell is a cell therapy candidate for preventing acute graft-versus-host diseasePeng-Jie Yang, Xiang-Yu Zhao, Yao-Hui Kou, et al.
Bone Marrow Transplantation|November 16, 2024
Pretransplantation risk factors for positive MRD after allogeneic stem cell transplantation in AML patients: a prospective studySi-Qi Li, Chun-Zi Yu, Lan-Ping Xu, et al.
British Journal of Haematology|April 29, 2023
Predicting short-term and long-term mortalities from sepsis in patients who receive allogeneic haematopoietic stem cell transplantationYe-Jun Wu, Hui-Xin Liu, Xiao-Lu Zhu, et al.
Plant Biotechnology Journal|June 15, 2019
Genome-wide identification and analysis of heterotic loci in three maize hybridsHongjun Liu, Qin Wang, Mengjiao Chen, et al.
Cancer Letters|June 6, 2022
CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemiaNai-Shan Zheng, Xiang-Yu Zhao, Ding Wei, et al.
Pageof 18